0001104659-24-034103.txt : 20240313
0001104659-24-034103.hdr.sgml : 20240313
20240313212250
ACCESSION NUMBER: 0001104659-24-034103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240311
FILED AS OF DATE: 20240313
DATE AS OF CHANGE: 20240313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wood Todd Michael
CENTRAL INDEX KEY: 0001739840
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34703
FILM NUMBER: 24747713
MAIL ADDRESS:
STREET 1: C/O OBALON THERAPEUTICS, INC.
STREET 2: 5421 AVENIDA ENCINAS, SUITE F
CITY: SAN DIEGO
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALIMERA SCIENCES INC
CENTRAL INDEX KEY: 0001267602
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 200028718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
BUSINESS PHONE: 678-990-5740
MAIL ADDRESS:
STREET 1: 6310 TOWN SQUARE
STREET 2: SUITE 400
CITY: ALPHARETTA
STATE: GA
ZIP: 30005
4
1
tm248828-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-03-11
0
0001267602
ALIMERA SCIENCES INC
ALIM
0001739840
Wood Todd Michael
6310 TOWN SQUARE, SUITE 400
ALPHARETTA
GA
30005
0
1
0
0
President of U.S. Operations
0
Restricted Stock Units
2024-03-11
4
A
0
125000
0.00
A
Common Stock
125000
125000
D
Performance-Based Restricted Stock Units
2024-03-11
4
A
0
125000
0.00
A
Common Stock
125000
125000
D
Each Restricted Stock Unit (RSU) represents a contingent right to receive one (1) share of the common stock of the Issuer.
Each Performance-Based Restricted Stock Unit (PSU) represents a contingent right to receive one (1) share of the common stock of the Issuer, subject to the achievement of applicable performance criteria.
The RSUs were awarded to the Reporting Person under the Alimera Sciences, Inc. 2024 Equity Inducement Plan. 25% of the RSUs are scheduled to vest on the first anniversary of the Reporting Person's employment commencement date and the remaining portion of the RSUs will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous employment with the Issuer on each such vesting date.
The PSUs were awarded to the Reporting Person under the Alimera Sciences, Inc. 2024 Equity Inducement Plan. Each PSU represents the right to receive, following vesting, one (1) share of common stock of the Issuer. 1/3 of the PSUs will vest for each performance year during the 3-year performance period beginning January 1, 2024 and ending on December 31, 2026 if either one of the pre-established annual revenue target and stock price target is satisfied during such performance year, as set forth in the Reporting Person's award agreement. The number of PSUs reported reflects the maximum number of PSUs that the Reporting Person may earn at the end of the 3-year performance period.
/s/ Todd Wood
2024-03-13